2012 journal article

Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin

VETERINARY PARASITOLOGY, 187(1-2), 23–27.

By: M. Di Cicco n, M. Downey n, E. Beeler*, H. Marr n, P. Cyrog, L. Kidd*, P. Diniz*, L. Cohn*, A. Birkenheuer n

author keywords: Protozoal; Babesiosis; Piroplasm; Babesia gibsoni
MeSH headings : Animals; Antiprotozoal Agents / administration & dosage; Antiprotozoal Agents / therapeutic use; Atovaquone / administration & dosage; Atovaquone / therapeutic use; Azithromycin / administration & dosage; Azithromycin / therapeutic use; Babesia / classification; Babesiosis / drug therapy; Babesiosis / epidemiology; Babesiosis / parasitology; Babesiosis / veterinary; California / epidemiology; Communicable Diseases, Emerging / epidemiology; Communicable Diseases, Emerging / parasitology; Communicable Diseases, Emerging / veterinary; Dog Diseases / drug therapy; Dog Diseases / epidemiology; Dog Diseases / genetics; Dog Diseases / parasitology; Dogs; Female; Male; Pedigree
TL;DR: Combination therapy with atovaquone and azithromycin appears to be effective for acute and chronic babesiosis caused by B. conradae. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: August 6, 2018

2011 journal article

Segmental jejunal entrapment, volvulus, and strangulation secondary to intra-abdominal adhesions in a dog

Journal of the American Animal Hospital Association, 47(3), E31–35.

By: M. Di Cicco, R. Bennett, C. Ragetly & K. Sippel

Source: NC State University Libraries
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.